Burkitt Lymphoma

A form of undifferentiated malignant LYMPHOMA usually found in central Africa, but also reported in other parts of the world. It is commonly manifested as a large osteolytic lesion in the jaw or as an abdominal mass. B-cell antigens are expressed on the immature cells that make up the tumor in virtually all cases of Burkitt lymphoma. The Epstein-Barr virus (HERPESVIRUS 4, HUMAN) has been isolated from Burkitt lymphoma cases in Africa and it is implicated as the causative agent in these cases; however, most non-African cases are EBV-negative.

Also Known As:

Burkitt's Lymphoma; Burkitt's Leukemia; Burkitts Lymphoma; Lymphoma, Burkitt's; Burkitt Leukemia; Burkitt's Tumor; Leukemia, Lymphoblastic, Burkitt-Type; Leukemia, Lymphocytic, L3; Lymphocytic Leukemia, L3; Burkitts Leukemia; Burkitts Tumor; L3 Lymphocytic Leukemia; L3 Lymphocytic Leukemias; Leukemia, Burkitt; Leukemia, Burkitt Cell; Leukemia, Burkitt's; Leukemia, L3 Lymphocytic; Lymphoma, African; Tumor, Burkitt; Tumor, Burkitt's; African Lymphoma; Burkitt Cell Leukemia; Burkitt Tumor; Lymphoma, Burkitt

Infections: 526564
- Virus Diseases: 41777
  - DNA Virus Infections: 139
    - Herpesviridae Infections: 821
      - Epstein-Barr Virus Infections: 3135
        Burkitt Lymphoma: 3456
  - Tumor Virus Infections: 39
    - Epstein-Barr Virus Infections: 3135
      - Burkitt Lymphoma: 3456
Neoplasms: 1324753
- Neoplasms by Histologic Type: 2
  - Lymphoma: 47916
    - Non-Hodgkin Lymphoma: 14954
      - B-Cell Lymphoma: 11416
        Burkitt Lymphoma: 3456
Hemic and Lymphatic Diseases: 6
- Lymphatic Diseases: 92
  - Lymphoproliferative Disorders: 4250
    - Lymphoma: 47916
      - Non-Hodgkin Lymphoma: 14954
        B-Cell Lymphoma: 11416
        Burkitt Lymphoma: 3456
Immune System Diseases: 4321
- Immunoproliferative Disorders: 29
  - Lymphoproliferative Disorders: 4250
    - Lymphoma: 47916
      - Non-Hodgkin Lymphoma: 14954
        B-Cell Lymphoma: 11416
        Burkitt Lymphoma: 3456

C Ouk-Martin Selected Research

C Ouk-Martin Research Topics

Disease

Drug/Important Bio-Agent (IBA)

Therapy/Procedure